Using bright light therapy to help reduce depressive symptoms in adults with intellectual disabilities

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the implementation of bright light therapy (BLT) for adults with intellectual disabilities who experience depressive symptoms. The research focuses on evaluating the process of implementing BLT at two different locations, starting with Amarant and then moving to Abrona. The study aims to gather insights on the effectiveness of BLT in reducing depressive symptoms and improving the quality of life for this population. Participants include both staff involved in the implementation and patients receiving the therapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Involved in the implementation of BLT (staff) OR
* Involved in the prescription or application of BLT (staff/relatives) OR
* receiving BLT for their depressive symptoms (patients with ID)
* 18 years or older
* informed consent

Exclusion Criteria:

* n/a

Where it's running

• ErasmusMC
  Rotterdam, Netherlands Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Morning Activation to Boost Mood After Stroke

  A six-week behavioral program is tested to see if it helps mood and daily functioning in adults who had a stroke and feel depressed or slow to get going in the morning.

  Recruiting The Hong Kong Polytechnic University · Hong Kong · NCT07719517

• Sleep More, Stress Less with Neuralli Mood

  This 90-day, open-label study tests whether daily Neuralli Mood capsules can help adults feel less stressed, sleep better, and improve mood and burnout symptoms.

  Recruiting Efforia, Inc · New York, New York · NCT07717385

• Blended Baduanjin and Green Tea Program for Depressive Symptoms in Older Adults

  This study tests whether a 12-week combo of gentle Baduanjin exercise and green tea consumption can help reduce depressive symptoms and improve gut health and quality of life in Hong Kong’s community-dwelling adults aged 65–84.

  Recruiting Hong Kong Baptist University · Kwun Tong · NCT07687940

• Metformin added to antidepressants for depression with obesity in Pakistani adults

  This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.

  Recruiting at 2 sites Riphah International University · Rawalpindi, Punjab Province and 1 other locations · NCT07654179

• rTMS with aerobic exercise for older adults with mild cognitive impairment and depressive symptoms

  This trial tests whether rTMS alone or rTMS plus stationary cycling can improve thinking skills and mood in older adults with MCI and depression.

  Recruiting Cheng-Hsin General Hospital · Taipei, Taipei City · NCT07652775

• Subanesthetic Ketamine for Depressive Symptoms in ICU Patients

  This study tests whether a short course of low-dose ketamine can help reduce depressive symptoms in adults who are in the ICU.

  Recruiting at 2 sites Phase 2 Hospital Italiano de Buenos Aires · Jacksonville, Florida and 1 other locations · NCT07639359

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.